Biogen

Biogen is a leading biotechnology company specializing in the discovery, development, and delivery of innovative therapies for neurological and neurodegenerative diseases. They generate revenue primarily through the sale of their proprietary drugs, such as treatments for multiple sclerosis and spinal muscular atrophy. Founded in 1978, Biogen has a rich history of scientific breakthroughs and was one of the first companies to focus on neurobiology, making significant contributions to the field of biotechnology.

Recent Posts by Biogen

1-20 of 1016